S. Clift

Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice.

A. Berns, P. Belloni, L. Cohen, 1995, Proceedings of the National Academy of Sciences of the United States of America.

A phase I study of vaccination with autologous, irradiated melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factor.

M. Mihm, G. Dranoff, A. Sober, 1997, Human gene therapy.

Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma.

F. Marshall, E. Jaffee, G. Dranoff, 1995, Human gene therapy.

High efficiency gene transfer into primary human tumor explants without cell selection.

F. Marshall, E. Jaffee, G. Dranoff, 1993, Cancer research.

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma.

D. Neuberg, M. Mihm, A. Berns, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Demonstration of a rational strategy for human prostate cancer gene therapy.

E. Jaffee, G. Dranoff, J. Epstein, 1994, The Journal of urology.

Serum vascular endothelial growth factor is a candidate biomarker of metastatic tumor response to ex vivo gene therapy of renal cell cancer.

F. Marshall, J. Simons, W. Nelson, 1998, Urology.